Bayer wants to amend Xarelto patent at centre of Sandoz’s invalidity claim
Intellectual Property 2022-07-15 11:37 am By Christine Caulfield

Save(0) Please login to bookmark Username or Email Address Password Remember Me German pharmaceutical giant Bayer, which is facing a legal bid by generic drug […]

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Want to test drive Lawyerly? Contact us to take a free trial.